Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 8Unknown 4Terminated 4Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

NIH 12OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Leiomyosarcoma 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × cediranib × Clear all
NCT03851614 2026-02-09

DAPPER

University Health Network, Toronto

Phase 2 Active not recruiting
90 enrolled
Sarcoma

Leiomyosarcoma

NCT04487587 2025-02-26

COMICE

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2 Active not recruiting
79 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡